Drug Candidate Request

Project Type

Quantity Unit:

Quality:

Drug Substance Or Drug Product Candidate Required

Quantity Amount:

Time Material Is Required

First Name

Last Name

Title

Company

Phone

Address

Optimi Health Corp.

21 Water St #600, Vancouver, BC V6B 1A1

Contact Information

E: investors@optimihealth.ca

T: +778-761-4551

Regulator Filings

Sedar Documents

Sedar Profile

Legal Counsel: Norton Rose Fulbright

Auditor: Smythe CPA

Transfer Agent: Endeavor Trust

Corporate Visibility & Investor Relations: Kydder Group

Trading Symbol: CSE: OPTI | OTC:OPTHF |

FRA: 8BN

CUSIP Number: 68405H100

ISIN Number: CA68405H1001

WKN: A2QQEL

Issued & Outstanding: (30/06/2022) 80,451,883

Incorporated: BC / May 27, 2020

Year End: September 30th

Privacy

Disclaimer

Product Disclaimer: Optimi Health products are still being investigated through a clinically validated development program for the purpose of applying for market authorization.

The safety and efficacy of our products has not been formally established.

Drug Candidate Request

Drug Candidate Request

Visit OptimiLife.com

Get news & updates directly to your inbox.

Interested In Optimi? Let's Talk.